Literature DB >> 1271082

[Myasthenia, thymoma and hypophyseal tumor associated with heterogenous adenomatous proliferation and ganglioneuroma of the sella turcica].

J Lapresle, J Racadot, G Said.   

Abstract

The authors report a case of myasthenia gravis in which a tumour of the sella turcica, without clinical symptoms, was discovered on X-ray examination of the skull and was removed with success. Histological study showed endocrine and neural type cells with cells of intermediate type. Subsequent thoracic surgery was performed with removal of a thymoma which was not visible on X-ray examination of the chest. The first operation on the sella turcica had no effect on the myasthenia but after the second on the thymoma a definite improvement was noted. The association of myasthenia, thymoma and ganglioneuroma of the sella turcica is unknown. In order to explain this, the authors hypothesize a common origin in the neural crests of both tumours.

Entities:  

Mesh:

Year:  1976        PMID: 1271082     DOI: 10.1016/0022-510x(76)90107-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: acromegaly, amenorrhea-galactorrhea, Cushing's disease and isolated tumoral syndrome.

Authors:  J Y Li; O Racadot; M Kujas; M Kouadri; F Peillon; J Racadot
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Intrasellar hamartoma associated with pituitary adenoma.

Authors:  F Slowik; I Fazekas; K Bálint; L Gazsó; E Pásztor; S Czirják; K Lapis
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  Combined sellar fibrosarcoma and prolactinoma with neuronal metaplasia: report of a case unassociated with radiotherapy.

Authors:  Mario Moro; Caterina Giannini; Bernd W Scheithauer; Ricardo V Lloyd; Paul Restall; Carl Eagleton; Andrew J Law; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.